ArticleFrontiers in medicine2022

Corrigendum: JAK1/2 inhibitor baricitinib improves skin fibrosis and digital ulcers in systemic sclerosis.

Zhanying Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.